Molexa financials
A multi-period view of the public annual-account figures reported for Molexa, with comparable measures and links to available source documents.
Company overviewRegistry number
1011001801
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for Molexa
2025 versus 2024
- Operating line
- €23,237
- EBITDA
- €23,237
- Total assets
- €61,653
- Equity
- €44,560
-25.6%
-25.6%
+21.5%
+59.8%
EBITDA margin +100% · Equity ratio +72.3%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €23,237 | €23,237 | €61,653 | €44,560 | - |
| 202431 Dec 2024 | €31,237 | €31,237 | €50,736 | €27,885 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.